2025-10-172025-10-17http://hdl.handle.net/10400.8/14293Ataxia,Biochemical marker,RNA sequencing,Preclinical disease stage, Medical and health sciencesEuropean Spinocerebellar Ataxia Type 3/Machado-Joseph Disease InitiativeESMI